We are live on
!
Find out more
JO
John Overdeck Two Sigma Investments
AUM
$138B
1-Year Est. Return
41.87%
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
This Fund
S&P 500
This Quarter
Est. Return
+3.47%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$70.9B
AUM Growth
+$3.72B
(+5.5%)
Cap. Flow
+$541M
Cap. Flow
% of AUM
0.76%
Top 10 Holdings %
Top 10 Hldgs %
4.9%
Holding
4,545
New
899
Increased
1,598
Reduced
1,287
Closed
504
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$395M |
| 2 |
Vanguard Real Estate ETF
VNQ
|
+$321M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$318M |
| 4 |
ServiceNow
NOW
|
+$272M |
| 5 |
Schwab US REIT ETF
SCHH
|
+$248M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$547M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$447M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$377M |
| 4 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$299M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$269M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.53% |
| 2 | Financials | 13% |
| 3 | Industrials | 11.22% |
| 4 | Healthcare | 10.29% |
| 5 | Consumer Discretionary | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Blend Labs
BLND
$355M
| $759K | ﹤0.01% |
249,791
-319,780
| -56% | -$1.02M |
|
3002
Sun Communities
SUI
$15B
| $756K | ﹤0.01% |
6,100
-5,000
| -45% | -$626K |
|
3003
CALL
Thermo Fisher Scientific
TMO
$232B
| $753K | ﹤0.01% |
+1,300
| New | +$735K |
|
3004
Aligos Therapeutics
ALGS
$43.3M
| $752K | ﹤0.01% |
80,649
+41,654
| +107% | +$393K |
|
|
WHWK
3005
Whitehawk Therapeutics
WHWK
$278M
| $750K | ﹤0.01% |
+309,865
| New | +$711K |
|
3006
Exelon
EXC
$45.7B
| $750K | ﹤0.01% |
17,200
-2,500
| -13% | -$114K |
|
3007
Alpha Metallurgical Resources
AMR
$2.66B
| $750K | ﹤0.01% |
3,750
-45,807
| -92% | -$7.92M |
|
3008
Tigo Energy
TYGO
$80.6M
| $749K | ﹤0.01% |
542,911
+370,665
| +215% | +$742K |
|
3009
Bristow Group
VTOL
$1.36B
| $747K | ﹤0.01% |
+20,391
| New | +$768K |
|
|
TIC
3010
TIC Solutions Inc
TIC
$2.03B
| $744K | ﹤0.01% |
73,553
-13,826
| -16% | -$154K |
|
3011
Healthcare Services Group
HCSG
$1.56B
| $743K | ﹤0.01% |
38,855
-51,225
| -57% | -$922K |
|
3012
Invesco Biotechnology & Genome ETF
PBE
$401M
| $739K | ﹤0.01% |
+9,000
| New | +$696K |
|
3013
SR Bancorp
SRBK
$143M
| $738K | ﹤0.01% |
46,860
+27,619
| +144% | +$424K |
|
3014
PUT
Gilead Sciences
GILD
$182B
| $736K | ﹤0.01% |
+6,000
| New | +$729K |
|
|
EFSI
3015
Eagle Financial Services Inc
EFSI
$227M
| $736K | ﹤0.01% |
18,492
-6,986
| -27% | -$261K |
|
3016
Lexicon Pharmaceuticals
LXRX
$1.03B
| $733K | ﹤0.01% |
637,308
+78,300
| +14% | +$108K |
|
|
XHR
3017
Xenia Hotels & Resorts
XHR
$1.81B
| $730K | ﹤0.01% |
+51,600
| New | +$704K |
|
3018
State Street SPDR S&P Pharmaceuticals ETF
XPH
$563M
| $728K | ﹤0.01% |
+13,000
| New | +$674K |
|
3019
CALL
Williams Companies
WMB
$86.8B
| $727K | ﹤0.01% |
+12,100
| New | +$732K |
|
3020
Sony
SONY
$142B
| $726K | ﹤0.01% |
28,363
-1,556
| -5% | -$43.7K |
|
3021
Principal Exchange-Traded Funds Principal Quality ETF
PSET
$28.9M
| $725K | ﹤0.01% |
9,500
+6,200
| +188% | +$473K |
|
3022
ALX Oncology
ALXO
$275M
| $723K | ﹤0.01% |
640,205
+33,534
| +6% | +$50.8K |
|
3023
Ferrovial N.V. Ordinary Shares
FER
$45.2B
| $721K | ﹤0.01% |
11,267
| – | – |
|
|
PDS
3024
Precision Drilling
PDS
$1.13B
| $720K | ﹤0.01% |
10,012
-8,100
| -45% | -$497K |
|
3025
Ziff Davis
ZD
$1.91B
| $718K | ﹤0.01% |
20,428
-11,212
| -35% | -$391K |
|
Similar funds
John Overdeck's Q4 2025 Portfolio in Review
As of Q4 2025, John Overdeck held 4,545 positions worth $70.9B, up 5.5% from $67.2B the previous quarter. Its ten largest holdings account for 4.9% of the portfolio.
John Overdeck's Q4 2025 filing shows 899 new, 1,598 increased, 1,287 reduced and 504 closed positions. Its largest new stake was Vanguard Real Estate ETF: 3,573,400 shares worth $316M. The largest sale was State Street Financial Select Sector SPDR ETF, an estimated $547M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Industrials.
- John Overdeck's largest Q4 2025 buy was Vanguard Real Estate ETF: 3,573,400 shares worth $316M.
- John Overdeck added most to State Street Technology Select Sector SPDR ETF in Q4 2025, an estimated $395M increase.
- John Overdeck's biggest Q4 2025 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $547M.
- John Overdeck fully exited State Street SPDR Dow Jones Industrial Average ETF Trust in Q4 2025, selling an estimated $240M.
- John Overdeck's ten largest holdings make up 4.9% of its $70.9B portfolio in Q4 2025.
- John Overdeck opened 899 new positions and closed 504 in Q4 2025.
- John Overdeck's portfolio value rose 5.5% quarter-over-quarter to $70.9B.
Based on Two Sigma Investments's 13F filing for Q4 2025, filed 17 Feb 2026.